Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers

Inclusion Criteria:

- Body mass index (BMI) 18.0-27.0 kg/m^2 (both inclusive)

- Considered generally healthy upon completion of medical history, physical
examination, vital signs, screening laboratory results, and electrocardiogram (ECG),
as judged by the Investigator (trial physician)

Exclusion Criteria:

- The receipt of any investigational medicinal product within 1 month prior to this
trial

- Current or previous treatment with growth hormone or IGF-I (insulin-like growth
factor-I)

- Female of childbearing potential who is pregnant, breast-feeding or intends to become
pregnant or is not using adequate contraceptive methods (adequate contraceptive
measures as required by local law or practice) for the duration of the trial

- Known presence or history of malignancy

- Diabetes mellitus

- Use of pharmacologic doses of glucocorticoids

- Use of anabolic steroids

- History of drug or alcohol abuse